Lanean...
Correlate tumor mutation burden with immune signatures in human cancers
BACKGROUND: Tumor mutation burden (TMB) has been associated with cancer immunotherapeutic response and cancer prognosis. Although many explorations have revealed that high TMB may yield many neoantigens to incite antitumor immune response, a systematic exploration of the correlation between TMB and...
Gorde:
| Argitaratua izan da: | BMC Immunol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6329192/ https://ncbi.nlm.nih.gov/pubmed/30634925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12865-018-0285-5 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|